Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
BMJ Oncology|October 2, 2026
Active surveillance for a small low-risk papillary thyroid cancer: a 10-year prospective, observational study in an Italian tertiary care centreEleonora Molinaro, Arianna Ghirri, Alessandro Prete, et al.
BMJ Oncology|January 31, 2025
Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trialLaurie Spehner, Emeline Orillard, Antoine Falcoz, et al.
BMJ Oncology|January 31, 2025
Feasibility of implementing a rapid-learning methodology to inform radiotherapy treatments: key professional stakeholders' viewsArbaz Kapadi, Gareth Price, Corinne Faivre-Finn, et al.
BMJ Oncology|January 31, 2025
NISCAHN: a phase II trial of nivolumab in patients with salivary gland carcinoma (Unicancer ORL-08)Jérôme Fayette, Caroline Even, Laurence Digue, et al.
BMJ Oncology|January 31, 2025
From prediction to practice: mitigating bias and data shift in machine-learning models for chemotherapy-induced organ dysfunction across unseen cancersMatthew Watson, Pinkie Chambers, Luke Steventon, et al.
BMJ Oncology|January 31, 2025
Repurposing radiosensitising medicines for radiotherapy: an overviewJie Man Low, Gonzalo Rodriguez-Berriguete, Geoff S Higgins
BMJ Oncology|January 31, 2025
Association of pre-existing cardiovascular disease with administration of fluoropyrimidine chemotherapy in patients with gastrointestinal malignanciesAderonke Temilade Abiodun, Chengsheng Ju, Catherine A Welch, et al.
BMJ Oncology|January 31, 2025
Blood-based DNA methylation markers for lung cancer predictionJustina Ucheojor Onwuka, Florence Guida, Ryan Langdon, et al.
BMJ Oncology|January 31, 2025
Preconsultation compassion video to reduce anxiety among patients referred to a cancer centre: a randomised control trialChristine Winn, Generosa Grana, Anthony Mazzarelli, et al.
BMJ Oncology|January 31, 2025
Patterns of cytotoxic T-cell densities in immunogenic endometrial cancers reveal a potential mechanism for differences in immunotherapy efficacyNeil Ryan, Mark Glaire, Thomas Walker, et al.
Pageof 17